TET2 and atrial fibrillation: In vivo and in vitro studies showed that hematopoietic-specific loss of Tet2-enhanced cardiomyocyte inflammasome activity and abnormal cardiomyocyte SR calcium handling may underlie associated AF pathogenesis.